pH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma.
about
Ligand-based targeted therapy: a novel strategy for hepatocellular carcinomaPolyethylenimine-functionalized silver nanoparticle-based co-delivery of paclitaxel to induce HepG2 cell apoptosis.Silver Nanoparticles Induce HePG-2 Cells Apoptosis Through ROS-Mediated Signaling PathwaysFabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo.Triptolide Inhibits Invasion and Tumorigenesis of Hepatocellular Carcinoma MHCC-97H Cells Through NF-κB SignalingAcidic pH-Triggered Drug-Eluting Nanocomposites for Magnetic Resonance Imaging-Monitored Intra-arterial Drug Delivery to Hepatocellular Carcinoma.pH-Sensitive Pt Nanocluster Assembly Overcomes Cisplatin Resistance and Heterogeneous Stemness of Hepatocellular CarcinomaCloning and functional characterization of an isopentenyl diphosphate isomerase gene from Tripterygium wilfordii.Targeted Nanotherapies for the Treatment of Surgical Diseases.pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells.Dynamic Nanoparticle Assemblies for Biomedical Applications.Effect of Combined Treatment Using Wilfortrine and Paclitaxel in Liver Cancer and Related Mechanism.MiR-15b mediates liver cancer cells proliferation through targeting BCL-2.Self-assembled autophagy-inducing polymeric nanoparticles for breast cancer interference in-vivo.The structural modification of natural products for novel drug discovery.Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma.Synergistic Anticancer Activities of Natural Substances in Human Hepatocellular Carcinoma.Nanoscale Coordination Polymers Codeliver Chemotherapeutics and siRNAs to Eradicate Tumors of Cisplatin-Resistant Ovarian Cancer.Surface Engineering of Nanoparticles for Targeted Delivery to Hepatocellular Carcinoma.The Effect of Triptolide in Rheumatoid Arthritis: From Basic Research towards Clinical Translation.In vivo aggregation-induced transition between T1 and T2 relaxations of magnetic ultra-small iron oxide nanoparticles in tumor microenvironment.A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F.Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
P2860
Q28068437-3567706A-5F96-47A9-B8C7-3D2DBD293269Q36229006-8D801918-D8D7-4938-A345-AADFB0E21F4BQ36795642-8389FFAC-32AC-4FA2-AF6D-374E5124165FQ37003881-CB3F1A90-0335-4C33-96AF-4D14919CD410Q37036012-F1DC53D5-7641-4B27-8B92-260AA39FC339Q37092372-27DFBFA2-DCAF-4DC1-B779-939A1A2C9066Q37449500-904808F2-38AD-4BD9-9DED-4B16F631BCD1Q38559198-61BCD909-CC03-44A6-A7DF-BC8F36B860F5Q38693341-2AAF5EC9-F50F-48CA-A836-216C93202DC6Q38694640-934ED7F8-9BFE-45A8-B450-337130878FA6Q38754625-D326A09A-0B58-450D-A754-309327B19140Q38780817-9287B55B-4801-4DC9-B4F5-9F3C1D58EEA9Q38793586-F7DCF5B5-231A-4567-8EDB-B89ECE8AD566Q38897962-13554AA9-3187-4562-A5D5-5809D92376DFQ39050184-6B547331-BA7A-4ED3-B62B-4186627DD959Q39358916-91EDB120-0C4F-4AE0-B6C0-21CF03E82842Q42343450-5A9BF60D-1DED-441C-AFF3-D63E7B57295CQ46940314-DBE74DC3-2DAC-4BF4-8F54-1109938FD3DFQ47240392-9BFE4A76-8629-4555-92DB-ADC75A7D8109Q48159281-15D16E24-D542-4B1F-96AF-74DFA8322D2EQ48253435-ABB87531-2996-4468-8DD2-9DEDA18E897CQ55407628-9024E4FE-3C77-4FB8-8FDD-96E31B992F08Q56797729-B8EB13AF-BE74-4AE8-AAAB-A330D2671B6F
P2860
pH-sensitive nanoformulated triptolide as a targeted therapeutic strategy for hepatocellular carcinoma.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
pH-sensitive nanoformulated tr ...... for hepatocellular carcinoma.
@ast
pH-sensitive nanoformulated tr ...... for hepatocellular carcinoma.
@en
type
label
pH-sensitive nanoformulated tr ...... for hepatocellular carcinoma.
@ast
pH-sensitive nanoformulated tr ...... for hepatocellular carcinoma.
@en
prefLabel
pH-sensitive nanoformulated tr ...... for hepatocellular carcinoma.
@ast
pH-sensitive nanoformulated tr ...... for hepatocellular carcinoma.
@en
P2093
P50
P356
P1433
P1476
pH-sensitive nanoformulated tr ...... y for hepatocellular carcinoma
@en
P2093
Changyeong Song
Hongping Xia
Michael J Hackett
Taeghwan Hyeon
P304
P356
10.1021/NN502074X
P407
P577
2014-08-01T00:00:00Z